Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
BRCA1-2 mutations in breast cancer: Identification of nine new variants of BRCA1-2 genes in a population from central Western Spain
ArticleAbstract: We carried out a mutational analysis of BRCA1 and BRCA2 genes in 103 individuals from a population iPalabras claves:BRCA1, BRCA2, Familial breast cancer, Pathogenic mutations, Silent mutations, Unclassified variantsAutores:Barco E., Cruz-Hernandez J.J., Fonseca E., Gomez-Bernal A., González-Sarmiento R., Portugal T., Raquel Salazar-Lugo, Rodríguez-Sánchez C.A., Sánchez-Valdivieso E.A.Fuentes:scopusUnraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach
ArticleAbstract: Background: An essential question in cancer is why individuals with the same disease have differentPalabras claves:Autores:Alonso-López D., Blanco-Gómez A., Bowen B., Castellanos-Martín A., Castillo-Lluva S., Cruz-Hernandez J.J., De Las Rivas J., Del Mar Abad M., García-Cenador M.B., García-Criado J., González-Sarmiento R., Hontecillas-Prieto L., Isidoro-García M., Lee D.Y., Mao J.H., Martín-Seisdedos C., Northen T., Patino-Alonso M.C., Perez-Losada J., Purificación Galindo-Villardón, Reindl W., Rodríguez-Sánchez C.A., Sáez-Freire M.d.M., Villar L.P.D.Fuentes:scopusSalamanca University Hospital experience in the adjuvant systemic treatment of loco-regional breast cancer. Results of a medical assistance protocol of a seven-year follow-up study
ArticleAbstract: Purpose: To evaluate the effectiveness of the adjuvant systemic therapy of breast cancer in terms ofPalabras claves:Adjuvant treatment, Anthracycline, Breast Cancer, chemotherapy, TamoxifenAutores:Cruz-Hernandez J.J., Del Barco Morillo E., Fonseca E., García Mata J., García R., Gomez-Bernal A., López Mateos Y., Martín G., Raquel Salazar-Lugo, Rodríguez-Sánchez C.A., Ruiz Martín M.I., Sanchez P.L.Fuentes:scopus